{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:01:14Z","timestamp":1770717674271,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Kahn-Sagol-Maccabi Health-Tech Research and Innovation institution grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00417-025-06953-z","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T11:33:02Z","timestamp":1756726382000},"page":"3471-3481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Parkinson\u2019s disease incidence in glaucoma patients from israel: insights from a 20-year follow-up sample"],"prefix":"10.1007","volume":"263","author":[{"given":"Yuval","family":"Kozlov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noa","family":"Geffen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiri","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon","family":"Zahavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orly","family":"Gal-Or","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assaf","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivan","family":"Gazit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tal","family":"Patalon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Meshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"6953_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1017\/S1463423609990193","volume":"10","author":"A Worley","year":"2009","unstructured":"Worley A, Grimmer-Somers K (2009) Should we be worried about glaucoma? Why the prevalence of glaucoma is variably reported. Prim Health Care Res Dev 10:343\u2013356. https:\/\/doi.org\/10.1017\/S1463423609990193","journal-title":"Prim Health Care Res Dev"},{"key":"6953_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology 121:2081\u20132090. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013","journal-title":"Ophthalmology"},{"key":"6953_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40662-017-0071-0","volume":"4","author":"YB Liang","year":"2017","unstructured":"Liang YB, Zhang Y, Musch DC, Congdon N (2017) Proposing new indicators for glaucoma healthcare service. Eye Vis (Lond) 4:6. https:\/\/doi.org\/10.1186\/s40662-017-0071-0","journal-title":"Eye Vis (Lond)"},{"key":"6953_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/genes14010111","volume":"14","author":"JN Cooke Bailey","year":"2022","unstructured":"Cooke Bailey JN, Funk KL, Cruz LA, Waksmunski AR, Kinzy TG, Wiggs JL, Hauser MA (2022) Diversity in polygenic risk of primary open-angle glaucoma. Genes (Basel) 14:111. https:\/\/doi.org\/10.3390\/genes14010111","journal-title":"Genes (Basel)"},{"key":"6953_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: A review. JAMA 323:548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"6953_CR6","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1212\/CON.0000000000001151","volume":"28","author":"D Weintraub","year":"2022","unstructured":"Weintraub D, Irwin D (2022) Diagnosis and treatment of cognitive and neuropsychiatric symptoms in Parkinson disease and dementia with lewy bodies. Continuum (Minneap Minn) 28:1314\u20131132. https:\/\/doi.org\/10.1212\/CON.0000000000001151","journal-title":"Continuum (Minneap Minn)"},{"key":"6953_CR7","doi-asserted-by":"publisher","first-page":"799526","DOI":"10.3389\/fnins.2021.799526","volume":"15","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang X, Yue Y, Tian T (2022) Retinal degeneration: A window to understand the origin and progression of parkinson\u2019s disease? Front Neurosci 15:799526. https:\/\/doi.org\/10.3389\/fnins.2021.799526","journal-title":"Front Neurosci"},{"key":"6953_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/jamaophthalmol.2022.5928","volume":"141","author":"S Ahn","year":"2023","unstructured":"Ahn S, Shin J, Song SJ, Yoon WT, Sagong M, Jeong A, Kim JH, Yu HG (2023) Neurologic dysfunction assessment in Parkinson disease based on fundus photographs using deep learning. JAMA Ophthalmol 141:234\u2013240. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.5928","journal-title":"JAMA Ophthalmol"},{"key":"6953_CR9","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1080\/03007995.2017.1322570","volume":"33","author":"SW Lai","year":"2017","unstructured":"Lai SW, Lin CL, Liao KF (2017) Glaucoma correlates with increased risk of parkinson\u2019s disease in the elderly: A national-based cohort study in Taiwan. Curr Med Res Opin 33:1511\u20131516. https:\/\/doi.org\/10.1080\/03007995.2017.1322570","journal-title":"Curr Med Res Opin"},{"key":"6953_CR10","doi-asserted-by":"publisher","first-page":"e108938","DOI":"10.1371\/journal.pone.0108938","volume":"9","author":"IC Lin","year":"2014","unstructured":"Lin IC, Wang YH, Wang TJ, Wang IJ, Shen YD, Chi NF, Chien LN (2014) Glaucoma, alzheimer\u2019s disease, and parkinson\u2019s disease: an 8-year population-based follow-up study. PLoS ONE 9:e108938. https:\/\/doi.org\/10.1371\/journal.pone.0108938","journal-title":"PLoS ONE"},{"key":"6953_CR11","doi-asserted-by":"publisher","first-page":"11161","DOI":"10.1038\/s41598-018-29557-6","volume":"8","author":"JY Moon","year":"2018","unstructured":"Moon JY, Kim HJ, Park YH, Park TK, Park EC, Kim CY, Lee SH (2018) Association between open-angle glaucoma and the risks of alzheimer\u2019s and parkinson\u2019s diseases in South korea: A 10-year nationwide cohort study. Sci Rep 8:11161. https:\/\/doi.org\/10.1038\/s41598-018-29557-6","journal-title":"Sci Rep"},{"key":"6953_CR12","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1111\/febs.16774","volume":"290","author":"E Lafont","year":"2023","unstructured":"Lafont E, Avril T (2023) A novel optineurin stress connection in glaucoma. FEBS J 290:3105\u20133109. https:\/\/doi.org\/10.1111\/febs.16774","journal-title":"FEBS J"},{"key":"6953_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fnagi.2017.00214","volume":"9","author":"AI Ramirez","year":"2017","unstructured":"Ramirez AI, de Hoz R, Salobrar-Garcia E, Salazar JJ, Rojas B, Ajoy D, L\u00f3pez-Cuenca I, Rojas P, Trivi\u00f1o A, Ram\u00edrez JM (2017) The role of microglia in retinal neurodegeneration: alzheimer\u2019s disease, parkinson, and glaucoma. Front Aging Neurosci 9:214. https:\/\/doi.org\/10.3389\/fnagi.2017.00214","journal-title":"Front Aging Neurosci"},{"key":"6953_CR14","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4103\/1673-5374.179053","volume":"11","author":"JL Vargas","year":"2016","unstructured":"Vargas JL, Di Polo A (2016) Neuroinflammation in glaucoma: soluble tumor necrosis factor alpha and the connection with excitotoxic damage. Neural Regen Res 11:424\u2013426. https:\/\/doi.org\/10.4103\/1673-5374.179053","journal-title":"Neural Regen Res"},{"key":"6953_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/a-2239-0290","volume":"241","author":"J Prinz","year":"2024","unstructured":"Prinz J, Walter P, Liu H, Prokosch V (2024) The impact of aging on the function of retinal ganglion cells. Klin Monbl Augenheilkd 241:162\u2013169. https:\/\/doi.org\/10.1055\/a-2239-0290","journal-title":"Klin Monbl Augenheilkd"},{"key":"6953_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","volume":"16","author":"SY Pang","year":"2019","unstructured":"Pang SY, Ho PW, Liu HF, Leung CT, Li L, Chang EES, Ramsden DB, Ho SL (2019) The interplay of aging, genetics and environmental factors in the pathogenesis of parkinson\u2019s disease. Transl Neurodegener 16:8:23. https:\/\/doi.org\/10.1186\/s40035-019-0165-9","journal-title":"Transl Neurodegener"},{"key":"6953_CR17","doi-asserted-by":"publisher","first-page":"e5921","DOI":"10.1097\/MD.0000000000005921","volume":"96","author":"YW Yang","year":"2017","unstructured":"Yang YW, Hsieh TF, Li CI, Liu CS, Lin WY, Chiang JH, Li TC, Lin CC (2017) Increased risk of Parkinson disease with diabetes mellitus in a population-based study. Med (Baltim) 96:e5921. https:\/\/doi.org\/10.1097\/MD.0000000000005921","journal-title":"Med (Baltim)"},{"key":"6953_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JPD-2011-11024","volume":"1","author":"O Chillag-Talmor","year":"2011","unstructured":"Chillag-Talmor O, Giladi N, Linn S, Gurevich T, El-Ad B, Silverman B, Friedman N, Peretz C (2011) Use of a refined drug tracer algorithm to estimate prevalence and incidence of parkinson\u2019s disease in a large Israeli population. J Parkinsons Dis 1:35\u201347. https:\/\/doi.org\/10.3233\/JPD-2011-11024","journal-title":"J Parkinsons Dis"},{"key":"6953_CR19","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/03007995.2022.2070377","volume":"38","author":"B Zhao","year":"2022","unstructured":"Zhao B, Cheung R, Malvankar-Mehta MS (2022) Risk of parkinson\u2019s disease in glaucoma patients: a systematic review and meta-analysis. Curr Med Res Opin 38:955\u2013962. https:\/\/doi.org\/10.1080\/03007995.2022.2070377","journal-title":"Curr Med Res Opin"},{"key":"6953_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0002-9394(01)01196-5","volume":"133","author":"AU Bayer","year":"2002","unstructured":"Bayer AU, Keller ON, Ferrari F, Maag KP (2002) Association of glaucoma with neurodegenerative diseases with apoptotic cell death: alzheimer\u2019s disease and parkinson\u2019s disease. Am J Ophthalmol 133:135\u2013137. https:\/\/doi.org\/10.1016\/S0002-9394(01)01196-5","journal-title":"Am J Ophthalmol"},{"key":"6953_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ogla.2020.06.008","volume":"3","author":"O Umunakwe","year":"2020","unstructured":"Umunakwe O, Gupta D, Tseng H (2020) Association of open-angle glaucoma with non-Alzheimer\u2019s dementia and cognitive impairment. Ophthalmol Glaucoma 3:460\u2013465. https:\/\/doi.org\/10.1016\/j.ogla.2020.06.008","journal-title":"Ophthalmol Glaucoma"},{"key":"6953_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3233\/JPD-150685","volume":"5","author":"P Mahlknecht","year":"2015","unstructured":"Mahlknecht P, Seppi K, Poewe W (2015) The concept of prodromal parkinson\u2019s disease. J Parkinsons Dis 5:681\u2013697. https:\/\/doi.org\/10.3233\/JPD-150685","journal-title":"J Parkinsons Dis"},{"key":"6953_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/EB.S361946","volume":"14","author":"MA McDonald","year":"2022","unstructured":"McDonald MA, Stevenson CH, Kersten HM, Danesh-Meyer HV (2022) Eye movement abnormalities in glaucoma patients: A review. Eye Brain 14:83\u2013114. https:\/\/doi.org\/10.2147\/EB.S361946","journal-title":"Eye Brain"},{"key":"6953_CR24","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4103\/1673-5374.191211","volume":"11","author":"FJ Carreras","year":"2016","unstructured":"Carreras FJ (2016) Glaucoma and amyotrophic lateral sclerosis, two kindred diseases? Neural Regen Res 11:1415\u20131417. https:\/\/doi.org\/10.4103\/1673-5374.191211","journal-title":"Neural Regen Res"},{"key":"6953_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/EB.S293765","volume":"18","author":"JW Chan","year":"2021","unstructured":"Chan JW, Chan NCY, Sadun AA (2021) Glaucoma as neurodegeneration in the brain. Eye Brain 18:13:21\u201328. https:\/\/doi.org\/10.2147\/EB.S293765","journal-title":"Eye Brain"},{"key":"6953_CR26","doi-asserted-by":"publisher","first-page":"679092","DOI":"10.3389\/fnins.2021.679092","volume":"15","author":"PC Chen","year":"2021","unstructured":"Chen PC, Chung CC, Cheng YY, Chen WT, Hong CT, Chan L, Chien LN (2021) Retinal diseases and Parkinson disease: A population-based study. Front Neurosci 15:679092. https:\/\/doi.org\/10.3389\/fnins.2021.679092","journal-title":"Front Neurosci"},{"key":"6953_CR27","doi-asserted-by":"publisher","first-page":"193048","DOI":"10.1155\/2013\/193048","volume":"2013","author":"N Pescosolido","year":"2013","unstructured":"Pescosolido N, Parisi F, Russo P, Buomprisco G, Nebbioso M (2013) Role of dopaminergic receptors in glaucomatous disease modulation. Biomed Res Int 2013:193048. https:\/\/doi.org\/10.1155\/2013\/193048","journal-title":"Biomed Res Int"},{"key":"6953_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.aaf3934","volume":"357","author":"S Mittal","year":"2017","unstructured":"Mittal S, Bj\u00f8rnevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E, Jin M, Xu B, Xiang YK, Rochet JC, Engeland A, Rizzu P, Heutink P, Bartels T, Selkoe DJ, Caldarone BJ, Glicksman MA, Khurana V, Sch\u00fcle B, Park DS, Riise T, Scherzer CR (2017) \u03b22-Adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of parkinson\u2019s disease. Science 357:891\u2013898. https:\/\/doi.org\/10.1126\/science.aaf3934","journal-title":"Science"},{"key":"6953_CR29","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia Nigra and the etiology of parkinson\u2019s disease. Aging Cell 18:e13031. https:\/\/doi.org\/10.1111\/acel.13031","journal-title":"Aging Cell"},{"key":"6953_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1124\/jpet.120.000176","volume":"376","author":"CL Moore","year":"2021","unstructured":"Moore CL, Henry DS, McClenahan SJ, Ball KK, Rusch NJ, Rhee SW (2021) Metoprolol impairs \u03b21-Adrenergic Receptor-Mediated vasodilation in rat cerebral arteries: implications for \u03b2-Blocker therapy. J Pharmacol Exp Ther 376:127\u2013135. https:\/\/doi.org\/10.1124\/jpet.120.000176","journal-title":"J Pharmacol Exp Ther"},{"key":"6953_CR31","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1001\/jamaneurol.2014.1364","volume":"71","author":"R Inzelberg","year":"2014","unstructured":"Inzelberg R, Hassin-Baer S, Jankovic J (2014) Genetic movement disorders in patients of Jewish ancestry. JAMA Neurol 71:1567\u20131572. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1364","journal-title":"JAMA Neurol"},{"key":"6953_CR32","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1212\/WNL.0000000000009431","volume":"94","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Wang YJ (2020) Tobacco smoking and the reduced risk of Parkinson disease: A puzzle of 60 years. Neurology 94:860\u2013861. https:\/\/doi.org\/10.1212\/WNL.0000000000009431","journal-title":"Neurology"},{"key":"6953_CR33","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/eye.2017.292","volume":"32","author":"SM Law","year":"2018","unstructured":"Law SM, Lu X, Yu F, Tseng V, Law SK, Coleman AL (2018) Cigarette smoking and glaucoma in the united States population. Eye (Lond) 32:716\u2013725. https:\/\/doi.org\/10.1038\/eye.2017.292","journal-title":"Eye (Lond)"},{"key":"6953_CR34","doi-asserted-by":"publisher","first-page":"101261","DOI":"10.1016\/j.preteyeres.2024.101261","volume":"100","author":"GO Bou Ghanem","year":"2024","unstructured":"Bou Ghanem GO, Wareham LK, Calkins DJ (2024) Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments. Prog Retin Eye Res 100:101261. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101261","journal-title":"Prog Retin Eye Res"},{"issue":"Suppl 2","key":"6953_CR35","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.survophthal.2007.08.010","volume":"52","author":"MC Grieshaber","year":"2007","unstructured":"Grieshaber MC, Mozaffarieh M, Flammer J (2007) What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol 52(Suppl 2):S144-54. https:\/\/doi.org\/10.1016\/j.survophthal.2007.08.010","journal-title":"Surv Ophthalmol"},{"key":"6953_CR36","doi-asserted-by":"publisher","unstructured":"Yang L, Xie Y, Islam MR, Xu G (2022) Big data and artificial intelligence (AI) to detect glaucoma. In: Proceedings of the 2022 IEEE International Conference on Behavioural and Social Computing (BESC), Matsuyama, Japan 1\u20136. https:\/\/doi.org\/10.1109\/BESC57393.2022.9994958","DOI":"10.1109\/BESC57393.2022.9994958"},{"key":"6953_CR37","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/IJG.0000000000002281","volume":"32","author":"D Landau Prat","year":"2023","unstructured":"Landau Prat D, Zloto O, Kapelushnik N, Leshno A, Klang E, Sina S, Segev S, Soudry S, Ben Simon GJ (2023) Bid data analysis of glaucoma prevalence in Israel. J Glaucoma 32:962\u2013967. https:\/\/doi.org\/10.1097\/IJG.0000000000002281","journal-title":"J Glaucoma"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06953-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06953-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06953-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:39:18Z","timestamp":1770647958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06953-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["6953"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06953-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research complied with the principles of the Declaration of Helsinki and received approval from the Maccabi Health Services Institutional Review Board (Approval Number 0128-21-MHS).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived due to the retrospective nature of the study, which utilized anonymized electronic medical records and did not involve direct interaction with patients or identifiable personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}